is bpc 157 or tb 500 better Heal Harm: Body Protective Compound-157 in the Gray Zone BPC-157 vs. TB-500 | Peptides

Increases in resting heart rate are a recognised class effect of incretin-based therapies and have been reported with GLP-1 receptor agonists more broadly, as reflected in the Summary of Product Characteristics (SmPC) for licensed agents such as semaglutide (Wegovy) and liraglutide (Saxenda)

They're similar but not identical

A push uses IV access but a smaller volume and shorter administration time

Sermorelin is a slower, structural intervention that reshapes body composition and supports long-term hormonal health

Research also indicates that BPC-157 may influence nitric oxide regulation through multiple signaling axes, including VEGFR2-dependent pathways and the Srccaveolin-1eNOS signaling cascade

BPC-157 offers a compelling option for patients looking to support tissue repair, reduce inflammation, and accelerate recovery under proper medical guidance